Return to homepagePandemic Pact

to determine the overall, age and gender specific prevalence of SARS CoV-2 in the general population of Gauteng, following the peak of the COVID-19 outbreak

Grant number: INV-023514

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $1,478,702

  • Funder

    Gates Foundation

  • Research Location

    South Africa

  • Lead Research Institution

    Wits Health Consortium (Pty) Ltd

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A

2 Publications linked via Europe PMC

Last Updated:3 days ago

View all publications at Europe PMC

Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study.

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.